{"id":176406,"date":"2022-03-28T20:51:07","date_gmt":"2022-03-28T15:21:07","guid":{"rendered":"https:\/\/blog.forumias.com\/?p=176406"},"modified":"2022-03-28T20:51:07","modified_gmt":"2022-03-28T15:21:07","slug":"on-trips-waiver-profit-over-public-health","status":"publish","type":"post","link":"https:\/\/forumias.com\/blog\/on-trips-waiver-profit-over-public-health\/","title":{"rendered":"On TRIPS waiver: Profit over public health\u00a0"},"content":{"rendered":"<p aria-level=\"1\"><\/p>\n<p><b><span data-contrast=\"none\">News<\/span><\/b><span data-contrast=\"none\">: In 2020, India and South Africa gave a call at the World Trade Organization (WTO)\u202ffor the Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver wrt Covid-19.<\/span><\/p>\n<p><span data-contrast=\"none\">Now,\u202fa<\/span> <span data-contrast=\"none\">deal has been brokered between the EU, the U.S., India, and South Africa on the issue.\u00a0 <\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:150,&quot;335559740&quot;:276}\"><br \/>\n<\/span><\/p>\n<p>However, the waiver is a classic case of too little, too late. This withered down version of the TRIPS waiver will further dent the WTO\u2019s relevance and credibility.<\/p>\n<h5><b><span data-contrast=\"auto\">What are the issues with the waiver?<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/h5>\n<p><span data-contrast=\"none\"><em><strong>First,<\/strong><\/em> the draft waiver <strong>does not cover any COVID-19 medical products other than Covid vaccines<\/strong>.<strong> For instance<\/strong>, baricitinib, which was recommended by WHO for treating critical COVID-19 will not be covered under it.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:150,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\"><em><strong>Second,<\/strong><\/em> India proposed to waive all IP rights, not just patents. But the <strong>waiver aims to waive only patents<\/strong>. The waivers do not cover other IP rights. <\/span><\/p>\n<p><span data-contrast=\"none\"><em><strong>Third,<\/strong><\/em> the draft waiver will allow the countries to export any proportion of vaccines that is produced domestically to eligible countries. This waiver is <strong>subject to several requirements.<\/strong> For example, <\/span><\/p>\n<p><span data-contrast=\"none\"><strong>&#8211;<\/strong> eligible members cannot re-export vaccines<\/span><\/p>\n<p><span data-contrast=\"none\"><strong>&#8211;<\/strong> WTO must be notified about every entity that has been authorised to produce the product<\/span><\/p>\n<p><span data-contrast=\"none\"><strong>&#8211;<\/strong> The authorization of Compulsory Licence (CL) must be on a product-by-product basis (Trip Plus Obligation) etc.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:150,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\"><em><strong>Fourth,<\/strong><\/em> the draft waiver is <strong>not applicable to the least developed countries<\/strong>. Only those developing countries that exported less than 10% of world exports of COVID-19 vaccine doses in 2021 are allowed for exportation and importation. <\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:150,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\"><em><strong>Fifth,<\/strong><\/em> t<\/span>he draft waives the obligation of a member to protect undisclosed information submitted before a drug regulator to claim marketing approval in the present context. But, it is <strong>silent on overcoming the challenges posed by protection to other trade secrets<\/strong> covered under Article 39.1 and 39.2 of TRIPS.<\/p>\n<h5>Have such waivers proved effective in the past?<\/h5>\n<p>No.<\/p>\n<p>In the aftermath of the HIV\/AIDS crisis in Africa, the WTO adopted a decision in 2003 waiving certain TRIPS obligations to increase the accessibility of medicines in countries that lacked manufacturing capability.<\/p>\n<p>However, this waiver was <strong>subject to stringent requirements<\/strong> because of which hardly any country made effective use of this waiver.<\/p>\n<h5><b><span data-contrast=\"none\">What is going to happen now?<\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:150,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h5>\n<p><span data-contrast=\"none\">The deal will now be presented to the entire WTO membership to be accepted at the forthcoming ministerial meeting.<\/span><\/p>\n<p><b><span data-contrast=\"auto\">Source<\/span><\/b><span data-contrast=\"auto\">: The post is based on an article \u201c<\/span><b><span data-contrast=\"auto\">Profit over public health<\/span><\/b><span data-contrast=\"auto\">\u201d published in <strong>The Hindu<\/strong> on <strong>28<\/strong><\/span><strong>th<\/strong><span data-contrast=\"auto\"><strong> Mar 22<\/strong>.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>News: In 2020, India and South Africa gave a call at the World Trade Organization (WTO)\u202ffor the Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver wrt Covid-19. Now,\u202fa deal has been brokered between the EU, the U.S., India, and South Africa on the issue.\u00a0 However, the waiver is a classic case of too little, too&hellip; <a class=\"more-link\" href=\"https:\/\/forumias.com\/blog\/on-trips-waiver-profit-over-public-health\/\">Continue reading <span class=\"screen-reader-text\">On TRIPS waiver: Profit over public health\u00a0<\/span><\/a><\/p>\n","protected":false},"author":10328,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[1230,9],"tags":[216,10498],"class_list":["post-176406","post","type-post","status-publish","format-standard","hentry","category-9-pm-daily-articles","category-public","tag-gs-paper-3","tag-the-hindu","entry"],"jetpack_featured_media_url":"","views":{"total":0,"cached_at":"","cached_date":1703292762},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/176406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/10328"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=176406"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/176406\/revisions"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=176406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/categories?post=176406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/tags?post=176406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}